[单项选择]Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress and the New York state attorney general. Now they’re becoming the catalyst for calls to reform the way clinical trials of all drugs are reported.
Pressure is already causing some changes within the pharmaceutical industry. And it has put the US Food and Drug Administration (FDA), which approves new drugs, in the hot seat. If reforms are carried out, they could bring an unprecedented level of transparency to drug research.
The solution now under consideration: a public database, or registry, of drug trials, where companies would post the results of those trials.
In congressional testimony Thursday, a spokesman for the American Medical Association endorsed the registry and said it should include information on each trial’s purpose and objective, its design, and the dates it begins and ends. If the trial is not completed, the registry should include
A. Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children.
B. The requirements of Congress and the New York state attorney general.
C. Changes within the pharmaceutical industry.
D. The information provided by a dozen influential medical journals.

更多"Growing concerns over the safety an"的相关试题:

[单项选择]Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress and the New York state attorney general. Now they’re becoming the catalyst for calls to reform the way clinical trials of all drugs are reported.
Pressure is already causing some changes within the pharmaceutical industry. And it has put the US Food and Drug Administration (FDA), which approves new drugs, in the hot seat. If reforms are carried out, they could bring an unprecedented level of transparency to drug research.
The solution now under consideration: a public database, or registry, of drug trials, where companies would post the results of those trials.
In congressional testimony Thursday, a spokesman for the American Medical Association endorsed the registry and said it should include information on each trial’s purpose and objective, its design, and the dates it begins and ends. If the trial is not completed, the registry should inclu
A. Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children.
B. The requirements of Congress and the New York state attorney general.
C. Changes within the pharmaceutical industry.
D. The information provided by a dozen influential medical journals.

查看答案

[单项选择]New concerns about growing religious tension in northern India were ______ this week after at least fifty people were killed and hundreds were injured or arrested in rioting between Hindus and Moslems.
A. lessened
B. invalidated
C. restrained
D. dispersed
E. fueled

查看答案

[单项选择]

{{B}}TEXT C{{/B}}

Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress and the New York state attorney general. Now they’re becoming the catalyst for calls to reform the way clinical trials of all drugs are reported.
Pressure is already causing some changes within the pharmaceutical industry. And it has put the US Food and Drug Administration (FDA), which approves new drugs, in the hot seat. If reforms are carried out, they could bring an unprecedented level of transparency to drug research.
The solution now under consideration: a public database, or registry, of drug trials, where companies would post the results of those trials.
In congressional testimony Thursday, a spokesman for the American Medical Association endorsed the registry and said it should include information on each trial’ s purpose and objective, its design, and the dates i
A. The pharmaceutical industry.
B. US Food and Drug Administration.
C. The Congress.
D. The drug companies.

查看答案

我来回答:

提交